Outlook Therapeutics (OTLK) Treasury Shares: 2015-2020
Historic Treasury Shares for Outlook Therapeutics (OTLK) over the last 4 years, with Jun 2020 value amounting to $2,470.
- Outlook Therapeutics' Treasury Shares fell 84.69% to $2,470 in Q2 2020 from the same period last year, while for Jun 2020 it was $2,470, marking a year-over-year decrease of 84.69%. This contributed to the annual value of $2,470 for FY2019, which is 84.69% down from last year.
- Per Outlook Therapeutics' latest filing, its Treasury Shares stood at $2,470 for Q2 2020, which was down 0.00% from $2,470 recorded in Q1 2020.
- Outlook Therapeutics' Treasury Shares' 5-year high stood at $1.2 million during Q4 2016, with a 5-year trough of $2,470 in Q3 2019.
- Over the past 3 years, Outlook Therapeutics' median Treasury Shares value was $16,131 (recorded in 2019), while the average stood at $50,225.
- Per our database at Business Quant, Outlook Therapeutics' Treasury Shares skyrocketed by 59.29% in 2016 and then plummeted by 98.09% in 2019.
- Over the past 5 years, Outlook Therapeutics' Treasury Shares (Quarterly) stood at $1.2 million in 2016, then slumped by 74.73% to $309,532 in 2017, then crashed by 58.29% to $129,095 in 2018, then plummeted by 98.09% to $2,470 in 2019, then tumbled by 84.69% to $2,470 in 2020.
- Its Treasury Shares stands at $2,470 for Q2 2020, versus $2,470 for Q1 2020 and $2,470 for Q4 2019.